Showing results (191-200 of 223) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
Level of HER2 gene amplification predicts response and overall survival in HER2-positive advanced gastric cancer treated with trastuzumabCarlos Gomez-Martin, Jose Carlos Plaza, Roberto Pazo-Cid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2022
Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER TrialJoan Albanell, José Manuel Pérez-García, Miguel Gil-Gil, et al.
Oncotarget|March 20, 2015
Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancerÓscar Aguilera, José Manuel González-Sancho, Sandra Zazo, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Comprehensive Approach to Genomic and Immune Profiling: Insights of a Real-World Experience in Gynecological TumorsIván Prieto-Potin, Franklin Idrovo, Ana Suárez-Gauthier, et al.
Therapeutic Advances in Medical Oncology|February 24, 2026
Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM)Sara López-Tarruella, Ángel Guerrero-Zotano, Silvia Antolín, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2026
Dynamic thymidine kinase activity independently captures treatment-specific biological response and is independently associated with outcomes in endocrine-resistant HR+ /HER2 - metastatic breast cancer: A translational analysis of the GEICAM/2013-02 PEARL trialÁngel Guerrero-Zotano, Miguel Gil-Gil, Amy Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2025
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA TrialFederico Rojo, Clive R Taylor, Carlos Barrios, et al.
Virchows Archiv : an International Journal of Pathology|March 8, 2025
Implementing digital pathology: qualitative and financial insights from eight leading European laboratoriesXavier Matias-Guiu, Jordi Temprana-Salvador, Pablo Garcia Lopez, et al.
Seminars in Cancer Biology|October 13, 2017
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerMaria Vittoria Dieci, Nina Radosevic-Robin, Susan Fineberg, et al.
JCO Precision Oncology|February 1, 2022
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor TherapyJoan Maurel, Vicente Alonso, Pilar Escudero, et al.
Pageof 23